Etelcalcetide
CAS No. 1262780-97-1
Etelcalcetide ( AMG 416; KAI-4169 )
Catalog No. M29934 CAS No. 1262780-97-1
Etelcalcetide (AMG 416) is a synthetic peptide as an activator of the calcium sensing receptor (CaSR). Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 101 | Get Quote |
|
10MG | 190 | Get Quote |
|
25MG | 384 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameEtelcalcetide
-
NoteResearch use only, not for human use.
-
Brief DescriptionEtelcalcetide (AMG 416) is a synthetic peptide as an activator of the calcium sensing receptor (CaSR). Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis.
-
DescriptionEtelcalcetide (AMG 416) is a synthetic peptide as an activator of the calcium sensing receptor (CaSR). Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis.
-
SynonymsAMG 416; KAI-4169
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1262780-97-1
-
Formula Weight1048.3
-
Molecular FormulaC38H73N21O10S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Block GA, et al. Effect of Etelcalcetide vs Cinacalcet on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: A Randomized Clinical Trial. JAMA. 2017 Jan 10;317(2):156-164.
molnova catalog
related products
-
Glycyl-L-glutamine m...
Glycyl-L-glutamine monohydrate is an inhibitory neuropeptide derived from beta-endorphin.
-
Ilexsaponin B2
Ilexsaponin B2 is a natural product for research related to life sciences.
-
Isobutylshikonin
Isobutylshikonin exhibits obvious antioxidant activities , it exerts very good radical scavenging activities toward ABTS+ but shows moderate inhibition of DPPH·.